Hafnia Limited Common Shares vs Tilray Brands Inc — how do they compare? Hafnia Limited Common Shares trades at $10.06 (market cap $5.67B), while Tilray Brands Inc trades at $3.1 (market cap $463.31M). The key difference: Hafnia Limited Common Shares is far larger — about 12.2× Tilray Brands Inc's market cap, and Hafnia Limited Common Shares pays a 10.44% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hafnia Limited Common Shares for 0 Days and Tilray Brands Inc for 31 Days on average.
| HAFN | TLRY | |
|---|---|---|
Market Cap | $5.67B | $463.31M |
Volume | 3,240,007 | 4,627,093 |
Sector | Industrials | Health |
52-Week High | $10.92 | $16.80 |
52-Week Low | $5.21 | $3.14 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $6.29B | $617.23M |
Dividend Yield | 10.44% | — |
Signals from Pluang's Aura AI — not financial advice
HAFN trades at $10.85, down 0.64% on the day, with a neutral technical signal. The company shows strong fundamentals, with a P/E of 8.35 and net income margin of 24.7%. Recent earnings have consistently beaten expectations, and analysts maintain a 100% buy rating. Key developments include a CEO transition and strategic acquisitions.
Outlook is positive due to robust profitability and growth projections, with 2026 revenue expected to reach $2.7B. Risks include market volatility and execution of new strategies. The stock presents a value opportunity with upside potential, supported by strong cash flow and institutional confidence.
TLRY trades at $3.27, down 2.68% on the day and near 52-week lows, reflecting persistent bearish pressure. The stock's technical indicators are mixed but overall signal remains negative. Fundamentally, the company reported a net loss of $2.19 billion in 2025 despite $821 million in revenue, with profitability metrics deeply negative. Recent news highlights continued stock weakness and strategic brand expansions under Tilray ownership.
The outlook is highly speculative; TLRY faces significant execution and profitability challenges, though analyst consensus suggests substantial upside potential from current levels. Key risks include ongoing losses, high debt levels, and regulatory uncertainty in the cannabis sector. Investment suitability is limited to high-risk tolerance investors betting on a operational turnaround or favorable regulatory shifts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hafnia Limited owns and operates a fleet of product and chemical tankers that transport refined oil products, vegetable oils, and chemicals for oil and chemical companies worldwide, across the Long Range, Medium Range, and Handy tanker segments, headquartered in Singapore.
Read more on HAFN →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →